First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 3.72 CAD -7% Market Closed
Updated: Jun 1, 2024

HLS Therapeutics Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Capital Expenditures Peer Comparison

Comparables:
M
MNX

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Capital Expenditures
-$191k
CAGR 3-Years
82%
CAGR 5-Years
28%
CAGR 10-Years
4%
M
Manitex Capital Inc
XTSX:MNX
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is HLS Therapeutics Inc's Capital Expenditures?
Capital Expenditures
-191k USD

Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Capital Expenditures amounts to -191k USD.

What is HLS Therapeutics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
4%

Over the last year, the Capital Expenditures growth was -74%. The average annual Capital Expenditures growth rates for HLS Therapeutics Inc have been 82% over the past three years , 28% over the past five years , and 4% over the past ten years .